Fixed snapshotThis page is a fixed snapshot of 2026-08-21 (UTC). It is never updated. The ranking that updates daily lives on the latest edition.

Past 24 hours

24-Hour Movers (2026-08-21)

A full-market scan narrowed to the ten biggest moves. Every attribution carries its evidence tier on the badge — first-party filing, press coverage, or an honest blank. Numbers only ever come from first-party sources.

Data updated: 2026-08-21 21:15
Instruments scanned: 309
Past 24 hours: 24 h

All times in UTC

Change

Rank1

Bitcoin Cash

BCH-USDT

+30.01%

CryptoGlobal

Last 24 hourly closes · 1H

BCH-USDT
Last price	286.80 USD
Change	+30.01%
Intraday range	36.83%
Volume vs baseline	17.8×
Sigma move	14.5 σ
Rank in past 100 days	#1
Move started	2026-08-21 06:00

CatalystUnattributedConfidence · Low

Up 30.0% over 24 hours on 17.8× baseline volume — no first-party event in the window lines up on both timing and scope.

Nothing in the window before the move began lines up on both timing and scope — not a first-party filing, not a press report. We would rather leave this blank than supply a reason that merely sounds plausible.

Sources

Measured from

First-partyOKXBCH-USDT spot candles (1H + 1Dutc)

Rank2

ENA

ENA-USDT

+24.83%

CryptoGlobal

Last 24 hourly closes · 1H

ENA-USDT
Last price	0.1419 USD
Change	+24.83%
Intraday range	41.13%
Volume vs baseline	n/a
Sigma move	3.4 σ
Rank in past 100 days	#2
Move started	n/a

CatalystUnattributedConfidence · Low

Up 24.8% over 24 hours — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

First-partyOKXENA-USDT spot candles (1H + 1Dutc)

Rank3

ZEC

ZEC-USDT

+24.61%

CryptoGlobal

Last 24 hourly closes · 1H

ZEC-USDT
Last price	721.91 USD
Change	+24.61%
Intraday range	28.04%
Volume vs baseline	3.2×
Sigma move	7.9 σ
Rank in past 100 days	#1
Move started	2026-08-21 07:00

CatalystUnattributedConfidence · Low

Up 24.6% over 24 hours on 3.2× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

First-partyOKXZEC-USDT spot candles (1H + 1Dutc)

Rank4

CRV

CRV-USDT

+19.90%

CryptoGlobal

Last 24 hourly closes · 1H

CRV-USDT
Last price	0.3326 USD
Change	+19.90%
Intraday range	21.37%
Volume vs baseline	17.0×
Sigma move	4.0 σ
Rank in past 100 days	#2
Move started	2026-08-21 02:00

CatalystUnattributedConfidence · Low

Up 19.9% over 24 hours on 17.0× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

First-partyOKXCRV-USDT spot candles (1H + 1Dutc)

Rank5

AAVE

AAVE-USDT

+19.61%

CryptoGlobal

Last 24 hourly closes · 1H

AAVE-USDT
Last price	116.81 USD
Change	+19.61%
Intraday range	21.59%
Volume vs baseline	4.8×
Sigma move	5.2 σ
Rank in past 100 days	#1
Move started	2026-08-21 07:00

CatalystUnattributedConfidence · Low

Up 19.6% over 24 hours on 4.8× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

First-partyOKXAAVE-USDT spot candles (1H + 1Dutc)

Rank6

PEPE

PEPE-USDT

+18.62%

CryptoGlobal

Last 24 hourly closes · 1H

PEPE-USDT
Last price	0.0000 USD
Change	+18.62%
Intraday range	29.47%
Volume vs baseline	n/a
Sigma move	5.1 σ
Rank in past 100 days	#1
Move started	n/a

CatalystUnattributedConfidence · Low

Up 18.6% over 24 hours — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

First-partyOKXPEPE-USDT spot candles (1H + 1Dutc)

Rank7

XPL

XPL-USDT

+17.62%

CryptoGlobal

Last 24 hourly closes · 1H

XPL-USDT
Last price	0.1018 USD
Change	+17.62%
Intraday range	24.12%
Volume vs baseline	n/a
Sigma move	3.7 σ
Rank in past 100 days	#3
Move started	n/a

CatalystUnattributedConfidence · Low

Up 17.6% over 24 hours — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

First-partyOKXXPL-USDT spot candles (1H + 1Dutc)

Rank8

PENGU

PENGU-USDT

+16.50%

CryptoGlobal

Last 24 hourly closes · 1H

PENGU-USDT
Last price	0.0084 USD
Change	+16.50%
Intraday range	21.45%
Volume vs baseline	n/a
Sigma move	4.7 σ
Rank in past 100 days	#1
Move started	n/a

CatalystUnattributedConfidence · Low

Up 16.5% over 24 hours — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

First-partyOKXPENGU-USDT spot candles (1H + 1Dutc)

Rank9

BONK

BONK-USDT

+16.41%

CryptoGlobal

Last 24 hourly closes · 1H

BONK-USDT
Last price	0.0000 USD
Change	+16.41%
Intraday range	22.72%
Volume vs baseline	9.0×
Sigma move	4.2 σ
Rank in past 100 days	#1
Move started	2026-08-21 07:00

CatalystUnattributedConfidence · Low

Up 16.4% over 24 hours on 9.0× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

First-partyOKXBONK-USDT spot candles (1H + 1Dutc)

Rank10

SELLAS Life Sciences Group, Inc.

SLS

+15.37%

US equitiesUnited States

Last 24 hourly closes · 1H

SLS
Last price	15.46 USD
Change	+15.37%
Intraday range	18.17%
Volume vs baseline	3.0×
Sigma move	2.8 σ
Rank in past 100 days	#5
Move started	2026-08-21 13:30opening bell

Part of this storySecondary (media)Confidence · Medium

SELLAS printed +15% in one session — and none of it came from the company. SELLAS filed nothing that day; what the tape was buying was the Moderna-Merck mRNA cancer-vaccine Phase 3 readout next door. Of the four same-day write-ups pinned to this card, two are asking about valuation and losses and one is openly asking what is drawing attention to the stock at all. Top-voted comment on r/smallstreetbets, 46 upvotes, is about options: “From what I've seen of the calls, a lot of people are already pricing in a big move. The premium is crazy”

MechanismThis is a repricing borrowed in full, and the four same-day write-ups happen to pin both ends of the loan to the same card. The heaviest of them carries the analyst line: Moderna-Merck's cancer-vaccine success “bodes well” for oncology — note that the subject of that sentence is the field, not this company. The other three turn the camera back on SELLAS itself: one asks whether it can turn sector hype into a durable cancer-vaccine story while the losses keep running; one says the stock looks stretched despite real progress in the key AML trial; the third is a question in its own headline — the shares moved, so what is actually drawing attention? The reason to buy, the reason not to, and an “I don't know” are all sitting on the same card, and we are not going to collapse them for the reader. Why the badge stops at secondary: SELLAS filed nothing with the SEC that day, so there is no first-party document anywhere on this line — every claim rests on someone else's readout and on second-hand coverage, and when we cannot get the primary source we say so instead of dressing it up. The news and the sentiment both built premarket; SLS gapped straight at the opening bell (13:30 UTC) and the move was priced there, so there is no lag to measure and we will not invent one.

Event time: 2026-08-20 · premarket
Lag: priced at the bell — not measurable

SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology

Image from the linked news article — Reddit

Open the post

What people said

Quoted verbatim, wording unchanged; the other languages are translations. Vote counts are a snapshot from the moment we fetched them.

From what I've seen of the calls, a lot of people are already pricing in a big move. The premium is crazy

u/MetalCharacter843146reddit

Press coverage only — no first-party filing came back. Confidence is therefore capped at medium: we know what happened, just not from the party it happened to.

Sources

Methodology

Evidence tier

First-partyA machine-readable endpoint run by the issuer, the exchange or the regulator itself.
Cross-verifiedTwo mutually independent sources report the same figure.
Secondary (media)Press coverage. Listed as a lead only; its figures never enter a measured field.
UnattributedNo catalyst was found. That is the normal case, not a failure.

Change: For crypto this is the exchange's rolling 24-hour figure (last price over the price 24 hours ago). For US equities it is the session change, previous close to last: US markets are shut about 17.5 hours a day, so a literal 24-hour window would fold two sessions into one number.
Volume vs baseline: Volume of the breakout bar divided by the median of the prior 20 bars. The baseline is a median, not a mean, so the spike cannot inflate its own denominator.
Sigma move: This move measured in standard deviations of the instrument's own 30-day realised volatility. The larger the number, the less it looks like ordinary noise.
Rank in past 100 days: Where this move ranks among the past 100 complete trading days. Rank 1 means the biggest in a hundred sessions.
Lag: Time between the catalyst event and the start of the move. If the event lands after the move began, the entry is marked unattributed.
Gap at the open: The news broke before the bell, so the repricing was finished by the time trading opened. This row's move starts at the opening bell itself, which means there is no lag to measure — and we do not print one.
Measured from: Price, volume and range for this row are measured here.
Leads: The events below pass the scope test but not the timing one — listed as leads, not as attributions.

Change

Up 30.0% over 24 hours on 17.8× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Up 24.8% over 24 hours — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Up 24.6% over 24 hours on 3.2× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Up 19.9% over 24 hours on 17.0× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Up 19.6% over 24 hours on 4.8× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Up 18.6% over 24 hours — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Up 17.6% over 24 hours — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Up 16.5% over 24 hours — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Up 16.4% over 24 hours on 9.0× baseline volume — no first-party event in the window lines up on both timing and scope.

Sources

Measured from

Top post at the time

SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology

What people said

Sources

Measured from

Catalyst source

Leads

Methodology

Evidence tier